ConductScience.org, home

Paper30108045

Loss of CXCR4 in Myeloid Cells Enhances Antitumor Immunity and Reduces Melanoma Growth through NK Cell and FASL Mechanisms.

Yang J and 7 others. Cancer Immunol Res, 2018. Cited by 62 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Loss of CXCR4 in Myeloid Cells Enhances Antitumor Immunity and Reduces Melanoma Growth through NK Cell and FASL Mechanisms. Papers, record 30108045. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30108045

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Loss of CXCR4 in Myeloid Cells Enhances Antitumor Immunity and Reduces Melanoma Growth through NK Cell and FASL Mechanisms.
PubMed
Journal
Cancer Immunol Res
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
62
iCite
Relative citation ratio, by iCite
1.73
iCite
Revised in PubMed
2023-02-23
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yang JJinming
2Kumar AAmrendra
3Vilgelm AEAnna E
4Chen SCSheau-Chiannhttps://orcid.org/0000-0002-5574-1434
5Ayers GDGregory D
6Novitskiy SVSergey V
7Joyce SSebastian
8Richmond AAnn

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cytotoxicity, ImmunologicMajor topic
Fas Ligand ProteinMajor topic
Killer Cells, NaturalMajor topic
Melanoma, ExperimentalMajor topic
Receptors, CXCR4Major topic
Animals
Bone Marrow Transplantation
Cell Line, Tumor
Interleukin-18
Macrophages
Mice, Inbred C57BL
Mice, Transgenic
Neutrophils

Source PubMed

Download CSV of topics

Grants11

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
S10 OD021804NIH HHSUnited StatesS10OD021804PubMedNIH RePORTER
I01 BX001444BLRD VAUnited StatesI01BX001444PubMed and NIHNIH RePORTER
R01 CA200681NCI NIH HHSUnited StatesR01CA200681PubMed and NIHNIH RePORTER
IK6 BX005225BLRD VAUnited StatesIK6BX005225PubMedNIH RePORTER
K12 CA090625NCI NIH HHSUnited StatesK12CA090625PubMedNIH RePORTER
R01 CA034590NCI NIH HHSUnited StatesR01CA034590PubMed and NIHNIH RePORTER
P30 CA068485NCI NIH HHSUnited StatesP30CA068485PubMed and NIHNIH RePORTER
R01 HL121139NHLBI NIH HHSUnited StatesR01HL121139PubMedNIH RePORTER
R01 CA116021NCI NIH HHSUnited StatesR01CA116021PubMed and NIHNIH RePORTER
IK6 BX004595BLRD VAUnited StatesIK6BX004595PubMed and NIHNIH RePORTER
I01 BX002301BLRD VAUnited StatesI01BX002301PubMed and NIHNIH RePORTER

Download CSV of grants

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124498562CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8+ T cells.Oncoimmunology2013https://conductscience.org/library/papers/24498562PubMed
217883327Chemokines and their receptors: drug targets in immunity and inflammation.Annu Rev Pharmacol Toxicol2008https://conductscience.org/library/papers/17883327PubMed
326967289The Basis of Oncoimmunology.Cell2016https://conductscience.org/library/papers/26967289PubMed
427471643Epithelial NF-κB signaling promotes EGFR-driven lung carcinogenesis via macrophage recruitment.Oncoimmunology2016https://conductscience.org/library/papers/27471643PubMed
511489989A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells.J Immunol2001https://conductscience.org/library/papers/11489989PubMed
625287686The intricate role of CXCR4 in cancer.Adv Cancer Res2014https://conductscience.org/library/papers/25287686PubMed
712563297Interleukin-12 and the regulation of innate resistance and adaptive immunity.Nat Rev Immunol2003https://conductscience.org/library/papers/12563297PubMed
89722546The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways.J Biol Chem1998https://conductscience.org/library/papers/9722546PubMed
99744279Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4.Nature1998https://conductscience.org/library/papers/9744279PubMed
1019451693Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer.J Clin Invest2009https://conductscience.org/library/papers/19451693PubMed
1121219185Natural innate and adaptive immunity to cancer.Annu Rev Immunol2011https://conductscience.org/library/papers/21219185PubMed
1212388552CXCR4 is a major chemokine receptor on glioma cells and mediates their survival.J Biol Chem2002https://conductscience.org/library/papers/12388552PubMed
1324056773CSF-1R inhibition alters macrophage polarization and blocks glioma progression.Nat Med2013https://conductscience.org/library/papers/24056773PubMed
1411509635A role for IL-18 in neutrophil activation.J Immunol2001https://conductscience.org/library/papers/11509635PubMed
1522258454Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity.Cancer Res2012https://conductscience.org/library/papers/22258454PubMed
1619088012Translating an Antagonist of Chemokine Receptor CXCR4: from bench to bedside.Clin Cancer Res2008https://conductscience.org/library/papers/19088012PubMed
1728369682Characterization and Functional Analysis of Mouse Semi-invariant Natural T Cells.Curr Protoc Immunol2017https://conductscience.org/library/papers/28369682PubMed
1819794494Membrane-bound Fas ligand only is essential for Fas-induced apoptosis.Nature2009https://conductscience.org/library/papers/19794494PubMed
1919282848Braf(V600E) cooperates with Pten loss to induce metastatic melanoma.Nat Genet2009https://conductscience.org/library/papers/19282848PubMed
2022393124Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis.J Exp Med2012https://conductscience.org/library/papers/22393124PubMed

See all 44 referencesDownload CSV of references

Cited by50

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.

PMIDTitleJournalYearIn PapersSource
42521772Spatial transcriptomics differences of histopathological growth patterns in colorectal cancer liver metastases.Br J Cancer2026https://conductscience.org/library/papers/42521772PubMed
42211393Inhibition of chemokine CXCL12 modulates the tumor microenvironment in glioblastoma and potentiates immune checkpoint inhibitor efficacy in a tissue-specific manner.Neurooncol Adv2026https://conductscience.org/library/papers/42211393PubMed
41582133Spatiotemporal dynamics of tumor-associated neutrophils: bridging the gap between cancer progression and immunotherapy.Mol Cancer2026https://conductscience.org/library/papers/41582133PubMed
41088352Turning cold tumors into hot tumors to ignite immunotherapy.Mol Cancer2025https://conductscience.org/library/papers/41088352PubMed
41044427The tumour microenvironment in pancreatic cancer - new clinical challenges, but more opportunities.Nat Rev Clin Oncol2025https://conductscience.org/library/papers/41044427PubMed
40835726Single-cell transcriptome analysis identifies MIF as a novel tumor-associated neutrophil marker for pancreatic ductal adenocarcinoma.NPJ Precis Oncol2025https://conductscience.org/library/papers/40835726PubMed
40656546Cancer-Associated Fibroblasts: Heterogeneity, Cancer Pathogenesis, and Therapeutic Targets.MedComm (2020)2025https://conductscience.org/library/papers/40656546PubMed
40461514Therapeutic potential of tumor-associated neutrophils: dual role and phenotypic plasticity.Signal Transduct Target Ther2025https://conductscience.org/library/papers/40461514PubMed
40251197Epithelial cell competition is promoted by signaling from immune cells.Nat Commun2025https://conductscience.org/library/papers/40251197PubMed
39998754Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy.Cell Oncol (Dordr)2025https://conductscience.org/library/papers/39998754PubMed
39567761The diverse roles of neutrophils from protection to pathogenesis.Nat Immunol2024https://conductscience.org/library/papers/39567761PubMed
39555061Neutrophils promote the activation of monocytes via ROS to boost systemic antitumor immunity after cryo-thermal therapy.Front Immunol2024https://conductscience.org/library/papers/39555061PubMed
39493309Xianling Lianxia formula improves the efficacy of trastuzumab by enhancing NK cell-mediated ADCC in HER2-positive BC.J Pharm Anal2024https://conductscience.org/library/papers/39493309PubMed
39339180Harnessing the Power of NK Cell Receptor Engineering as a New Prospect in Cancer Immunotherapy.Pharmaceutics2024https://conductscience.org/library/papers/39339180PubMed
38622975Heterogeneous characterization of neutrophilic cells in head and neck cancers.Head Neck2024https://conductscience.org/library/papers/38622975PubMed
38008741Exploiting innate immunity for cancer immunotherapy.Mol Cancer2023https://conductscience.org/library/papers/38008741PubMed
37815869Maternal CXCR4 deletion results in placental defects and pregnancy loss mediated by immune dysregulation.JCI Insight2023https://conductscience.org/library/papers/37815869PubMed
37014552Increased SPRY1 expression activates NF-κB signaling and promotes pancreatic cancer progression by recruiting neutrophils and macrophages through CXCL12-CXCR4 axis.Cell Oncol (Dordr)2023https://conductscience.org/library/papers/37014552PubMed
37010645Understanding the functional relevance of oral neutrophils, phenotype and properties in OSCC.Med Oncol2023https://conductscience.org/library/papers/37010645PubMed
36917949Activated fibroblasts in cancer: Perspectives and challenges.Cancer Cell2023https://conductscience.org/library/papers/36917949PubMed

See all 50 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CXCL126387PubTator's text mininghttps://conductscience.org/library/genes/6387NCBI Gene
CXCR47852PubTator's text mininghttps://conductscience.org/library/genes/7852NCBI Gene
ITGAM3684PubTator's text mininghttps://conductscience.org/library/genes/3684NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30108045

GET https://conductscience.org/api/papers/v1/30108045/references?page=2